Empowering Pharmacy Owners Through Expert Advisory
The ARx Ventures Difference
At ARx Ventures, we specialize in helping pharmacy owners and healthcare businesses grow, exit, or transition with confidence. With deep expertise in the pharmaceutical sector, our team delivers tailored M&A strategies that maximize value, reduce friction, and create lasting impact.
Build
•
Grow
•
Exit
•
Legacy
•
Partner
•
Trusted
•
Build • Grow • Exit • Legacy • Partner • Trusted •
Buy-Side Advisory
We partner with buyers to source, evaluate, and acquire pharmacies that align with their strategic objectives. Our industry-specific insights and targeted outreach uncover deals that drive meaningful growth.
Sell Side Representation
We work directly with pharmacy owners to guide them through confidential, high-impact exits. From initial valuation to final close, we handle the details — so owners can focus on what comes next.
Valuations & Strategy
We provide detailed valuations, financial modeling, and strategic guidance to pharmacy operators and investors. Whether you’re preparing to buy, sell, or scale, our data-driven insights lead the way.
Explore Our Services Here
Why work with ARx Ventures
Hi, I’m Arik Liberman — founder of ARx Ventures.
After nearly a decade leading operations and M&A in the healthcare and pharmaceutical space, I saw the need for something better: a more human, transparent way for pharmacy owners to navigate growth or exit. ARx Ventures was built to fill that gap — with a roll-up-your-sleeves approach that puts relationships first and results at the center.
We’re not just here to close deals — we’re here to create outcomes that matter.
What Sets Us Apart:
Real Pharmacy Experience
We know the ins and outs of the pharmacy business — and tailor every solution to the people behind it.Proven Results
My work has led to over $40M in growth and $6M in EBITDA gains — and we’re just getting started.Confidential, Owner-First Approach
We lead with trust, clarity, and care — no pressure, just honest guidance.
Arik Liberman, Founder and CEO of ARx Ventures
